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Background/Aims: E-cadherin is involved in intercellular binding and cellular polarity formation. Snail is a key regulator of the 
epithelial-mesenchymal transition and is closely associated with tumor invasiveness due to its ability to suppress E-cadherin 
expression. We investigated the expressions of E-cadherin and Snail in hepatocellular carcinoma (HCC) tissue to determine the 
clinical significance of these proteins in HCC. Methods: Immunohistochemistry was used to examine the expressions of 
E-cadherin and Snail in resected tissues from 59 patients diagnosed with HCC. We also evaluated the relationship between the 
expressions of these two molecules in HCC tissue and clinicopathologic factors in the patients. Results: Immunohistochemistry 
showed that Snail was stained in 20.3% of the HCC tissues and 3.4% of noncancerous tissues. Snail was not stained in the area 
of E-cadherin expression. The expression of Snail in the HCC tissue was associated with poorly differentiated HCC (P=0.028). 
The expression of Snail without E-cadherin staining in HCC tissue was significantly associated with postoperative HCC 
recurrence (P=0.013). Conclusions: The expression of Snail in HCC tissue was associated with decreased expression of 
E-cadherin and poorly differentiated HCC. The expression of Snail without E-cadherin staining in HCC was associated with 
postoperative recurrence. (Korean J Hepatol 2011;17:12-18)
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INTRODUCTION
Hepatocellular carcinoma (HCC) has been known to be 
the 3rd frequent cancer in Korea, and the mortality due to 
HCC has been reported to be high.
1 When detected in the 
advance stage, 5-year survival rate of HCC has been 
reported to be less than 10%, regardless of the treatment 
modalities.
2-4 Recently, early diagnosis of HCC is on the rise 
because of regular surveillance in high risk groups. If 
detected early, HCC could be completely cured by surgical 
resection or liver transplantation.
5,6 Nevertheless, if HCC 
recurs after such curative treatments, the survival rate of 
patients becomes noticeably low.
2,7 It has been reported that 
vascular infiltration of tumors has been reported to be an risk 
factor for recurrence of HCC.
8,9 The mechanism of vascular 
invasion of tumors has not been completely characterized, 
although recent studies reported that the process of epithelial 
mesenchymal transition might be associated with cancer 
metastasis.
10,11 It appears that cells transformed from epithelial 
cells to interstitial cells are connected loosely, and thus they 
could migrate readily, invasiveness becomes high, invade 
blood vessels and metastasized to other organs.
Snail, first identified in drosophila, plays an important 
role in the mesenchymal formation.
12 Snail is a transcription 
factor containing the helix-loop-helix structure, and it has 
been reported to suppress the transcription of E-cadherin, 
induce the expression of matrix metalloproteniase-2, and 
thus degrade extracellular matrix.
13-15 In previous reports on Hyun Young Woo, et al. Expression of Snail in hepatocellular carcinoma  13
Table 1. Characteristics of the patients
Characteristics Number of patients
Enrolled patients 59
Age (years)
* 57 (35-80)
Sex (male:female) 48/11
Causes 
  HBV/HCV/alcohol 43/8/8
Staging
  I/II/III/IVA/IVB  1/35/9/13/1
Tumor type 
  (nodular/infiltrative/multinodular) 56/1/2
Location (right/left/both) 41/11/7
Tumor size (cm)
* 3.5 (1.3-18)
Histologic grade
  I/II/III/IV 7/18/22/12
Portal vein invasion
  no/yes  45/14
HCC treatment
  OP/LT 34/25
Total bilirubin (mg/dL)
* 0.9 (0.4-32.2)
Albumin (g/dL)
* 3.7 (1.9-4.6)
Serum creatinine (mg/dL)
* 0.9 (0.5-10.5)
PT (INR)
* 1.2 (0.7-2.9)
AFP level (ng/mL)
* 161.5 (1.3-2907.0)
All data expressed as number of cases.
* Median (range).
HBV, hepatitis B virus; HCV, hepatitis C virus; OP, oper-
ation; LT, liver transplantation; PT, prothrombin time; AFP, α
-fetoprotein. 
the expression of Snail mRNA in HCC tissues, the expression 
of Snail has been shown to be significantly associated with 
the histological grade of differentiation of HCC, portal venous 
invasion and intrahepatic recurrence.
16,17 Nonetheless, such 
studies were conducted on HCC primarily associated with 
hepatitis C virus, and results of the studies on HCC associated 
with hepatitis B virus are known to be rare. We examined the 
expression of Snail and E-cadherin in resected tissues of 
HCC patients whose etiology was hepatitis B in most cases, 
and its relationship with pathophysiological characteristic of 
HCC and clinical outcomes of patients. 
PATIENTS AND METHODS
Patients
The study subjects were 59 HCC patients performed surgical 
resection or liver transplantation for HCC from 1997 to 2004 
at our hospital. First, the expression of Snail and E-cadherin 
in tissues obtained after surgery embedded in paraffin blocks 
was assessed by immunohistochemical analysis. After that, 
by using the medical record of subject patients, followings 
were examined; baseline clinical features, clinical courses after 
surgery, histological grade of differentiation, tumor stage, 
and the presence or absence of hepatic portal venous invasion. 
The study protocol conformed to the ethical guidelines of the 
1975 Declaration of Helsinki. This study was also approved 
by Kangnam St. Mary’s Hospital Institutional Review Board.
Immunohistochemical staining of Snail and 
E-cadherin
Immunohistochemical staining was performed on surgical 
specimen of the 59 HCC patients prepared as paraffin blocks. 
Briefly, the samples were treated with xylene to remove 
paraffin, and added to low concentrations of alcohol sequentially. 
The sections were added to methanol containing 3% 
hydrogen peroxide, and blocked with phosphate buffered 
saline containing 1% Bovine serum albumin. Then after the 
sections were reacted with rabbit polyclonal Snail antibody 
(DECMA-1, Cambridge,
 UK) diluted to 1:600 with phosphate 
buffered saline at 4℃ for 24 hours and rat monoclonal 
E-cadherin antibody (DECMA-1, Cambridge,
 UK) diluted 
to 1:500. Hydrogen peroxide was removed with the EnVision 
System, and kept at room temperature for 10 minutes. It was 
stained with 3,3‘-diaminobenzidine tetrachloride, washed, 
and as counterstaining, haematoxylin was used.
Assessment of immunohistochemical staining
To assess the staining of Snail and E-cadherin, tissue 
samples were examined at 200 times magnification, and 
classified as follows. Samples with more than 10% stained 
tumor cells were divided to 3 grades according to staining 
intensity and read. For Snail staining, samples with a portion 
of tumor cells not clearly stained were read as 1, samples 
with the nucleus of a portion of tumor cells or the entire 
tumor cells stained at moderate intensity were 2, and samples 
with the nucleus of a portion of tumor cells or the entire 
tumor cells stained strongly were 3. For E-cadherin staining, 
samples with the stained cytoplasm was 1, weak staining of 
cell membrane of a portion of tumor cells or the entire tumor 
cells was 2, and the noticeable staining of cell membrane of 14  The Korean Journal of Hepatology Vol. 17. No. 1, March 2011
Figure 1. Immunohistochemical staining patterns of Snail and E-cadherin in hepatocellular carcinomas (HCCs). (A) Positive staining 
of Snail is seen in the tumor portion. (B) E-cadherin is not stained in the tumor portion where they show positive staining for Snail. 
(C) Positive staining of E-cadherin is noted in the cytomembrane of the tumor portion. (D) Snail is not stained in the tumor portion 
where they show positive staining for E-cadherin (A: Snail, ×400, B: E-cadherin, ×400, C: E-cadherin, ×400, D: Snail, ×400).
a portion of tumor cells or the entire cells was 3. For 
statistical analysis, no staining or staining 1 were considered 
as negative, and staining 2 and 3 were considered as positive.
Clinical and pathological factors of HCC
As clinical factors, the age of patients, gender, the cause 
of HCC, serum alpha-fetoprotein level, tumor stage, the size 
of HCC, number, location, and morphological type were 
analyzed. The disease stage of tumor disease was evaluated 
according to the modified 5th UICC classification based on 
the primary liver cancer code of the Korean liver cancer 
research society.
18 Pathophysiologically, the presence or absence 
of portal venous invasion of HCC and the histological 
differentiation grade classified according to the Edmondson- 
Steiner’s grade I, II, III, and IV
19 was analyzed in association 
with the expression of Snail and E- cadherin.
Statistical analysis
To evaluate the association of the expression of Snail and 
E-cadherin to clinical and pathological factors of HCC, 
Fisher’s exact test or Mann-Whitney’s U-test was used as 
appropriately. The postsurgical recurrence rate of the Snail 
positive and negative group, and that of the E-cadherin positive 
and negative group were compared applying Kaplan-Meier 
survival analysis and log-rank test. Statistical significance of 
the result of analysis was determined by P-value<0.05. All 
statistical analysis was performed by the SPSS version 12.0 
(SPSS Inc, Chicago, IL, USA).
RESULTS
The characteristics of the patients
The mean age of the 59 patients was 57 years (range, 
A  B
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Table 2. Clinicopathologic features according to the expressions of Snail and E-cadherin 
Characteristics
Snail
P-value
E-cadherin
P-value
Positive (n=12) Negative (n=38) Positive (n=26) Negative (n=33)
Age (years)
* 54 (39-69) 58 (35-80) 0.113
† 57 (37-73) 58 (35-80) 0.988
†
Sex (male:female) 10/2 38/9 0.844
‡ 19/7 29/4 0.147
‡
Causes, HBV/HCV/alcohol 10/0/2 33/8/6 0.305
‡ 18/3/5 25/5/3 0.515
‡
Staging, I/II/III/IVA  1/6/1/4 0/29/8/10 0.220
‡ 1/10/7/8 0/25/2/6 0.059
‡
Tumor type 
 (nodular/infiltrative/multinodular) 12/0/0 44/1/2 0.668
‡ 24/1/1 32/0/1 0.514
‡
Location, right/left/both 9/2/1 32/9/6 0.880
‡ 16/4/6 25/7/1 0.140
‡
Tumor size (cm)
* 3.5 (1.5-5.5) 4 (1.3-18.0) 0.390
† 3.7 (1.3-12) 3.5 (1.7-18) 0.501
†
Histologic grade, I/II/III/IV 0/3/3/6 7/15/19/6 0.028
‡ 4/10/7/5 3/8/15/7 0.421
‡
Portal vein invasion, no/yes 7/5 38/9 0.102
‡ 19/7 26/7 0.609
‡
HCC treatment, OP/LT 8/4 26/21 0.478
‡ 12/14 22/11 0.184
‡
Total bilirubin (mg/dL)
* 0.8 (0.6-8.4) 0.9 (0.4-32.1) 0.888
† 0.9 (0.4-32.1) 0.8 (0.4-16.7) 0.219
†
Albumin (g/dL)
* 3.5 (2.3-4.4) 3.7 (1.9-4.6) 0.940
† 3.7 (1.9-4.6) 3.7 (2.3-4.5) 0.748
†
Serum creatinine (mg/dL)
* 0.8 (0.6-8.4) 0.9 (0.5-10.5) 0.785
† 0.8 (0.7-8.4) 0.9 (0.5-10.5) 0.636
†
PT (INR)
* 1.1 (0.9-2.9) 1.2 (0.7-2.8) 0.672
† 1.2 (0.8-2.8) 1.1 (0.7-2.8) 0.849
†
AFP level (ng/mL)
* 362.0 (18.0-2475.0) 62.7 (1.3-2907.0) 0.105
† 56.1 (1.26-1521.1) 238.8 (2.6-2907.0) 0.099
†
All data expressed as number of cases.
* Median (range), 
†Mann-Whitney test, 
‡Fisher’s exact test.
HBV, hepatitis B virus; HCV, hepatitis C virus; OP, operation; LT, liver transplantation; PT, prothrombin time; AFP, α-fetoprotein. 
35-80 years). Forty eight patients was male (81.4%). As the 
cause of HCC, 43 cases was hepatitis B (72.9%), which was 
most prevalent, and hepatitis C was 8 cases (13.6%). Among 
the all patients, 34 patients received surgical resection, and 
25 patients received liver transplantation. The mean score of 
the Model for End Stage Liver Disease at the time of the 
radical treatment was 10.8 (range, 6-30). The median serum 
alpha-fetoprotein was 161.5 ng/mL (range, 1.26-2,907 ng/mL). 
In regard to the HCC stage, 1 case (1.7%) was stage 1, 35 
cases (59.3%) was stage 2, 9 cases (15.3%) was stage 3, and 
14 cases (23.7%) was stage 4. The mean diameter of tumor 
was 5 cm, 40 cases (67.8%) were smaller than 5 cm, and 19 
cases (32.2%) were larger than 5 cm. The tumor was solitary 
in 71.2%. Regarding the morphological type of tumors, 56 
cases (94.9%) was nodular type, 1 case (1.7%) was infiltrative 
type, and 2 cases (3.4%) was multinodular type. Concerning 
the histological differentiation grade of HCC, grade I/II/III/IV 
was 7/18/22/12, respectively, and cases with portal vein invasion 
were 14 patients (23.7%) (Table 1).
Immunohistochemical staining of Snail and 
E-cadherin
Snail was expressed in the HCC in 12 cases (20.3%) and 
in the adjacent non-HCC in 2 cases (3.4%). E-cadherin was 
expressed in the cytoplasmic membrane of HCC in 26 cases 
(44.1%). In addition, in all cases, in the HCC area expressing 
Snail, the expression of E-cadherin was suppressed (Fig. 1).
The expression of Snail and E-cadherin and 
clinicopathological factors of HCC
The expression of Snail according to the histological grade 
of differentiation in HCC was 0 case (0%) in grade I, 3 cases 
(16.7%) in grade II, 3 cases (13.6%) in grade III, and 6 cases 
(50%) in grade IV, respectively (P=0.028). In addition, 
regarding the expression of Snail according to the portal 
vein invasion, it was expressed in 7 cases without portal vein 
invasion (15.5%), and 5 cases with the invasion (35.7%). 
Although the expression was increased in cases with portal 
vein invasion, it was not statistically significant (P=0.102). 
The etiology of HCC, tumor stage, the size, number and 
morphological type of HCC were not significantly associated 
with the expression of Snail and E-cadherin (P>0.05) (Table 2). 
When the clinicopathological factors according to the 
expression of E-cadherin in the group with or without Snail 
expression were compared, in the group with Snail expression 
and the group without the expression, clinicopathological 
factors were not significantly different according to the 
expression of E-cadherin (Table 3).16  The Korean Journal of Hepatology Vol. 17. No. 1, March 2011
Table 3. Clinicopathologic features according to the expression of E-cadherin, and subgroup analysis of Snail expression
Characteristics
Snail positive
P-value
Snail negative
P-value E-cadherin E-cadherin
Positive (n=6) Negative (n=6) Positive (n=20) Negative (n=27)
Age (years)
* 54 (39-69) 53 (44-68) 0.818
† 58 (37-73) 58 (35-80) 1.000
†
Sex (male:female) 4/2 6/0 0.455
‡ 15/5 23/4 0.465
‡
Causes, HBV/HCV/alcohol 4/0/2 6/0/0 0.455
‡ 14/3/3 19/5/3 0.896
‡
Staging, II+II/IVA+VB 5/1 3/3 0.545
‡ 13/7 24/3 0.073
‡
Tumor type
 (nodular/infiltrative/multinodular)
6/0/0 6/0/0 18/1/1 26/0/1 0.486
‡
Location, right/left/both 3/2/1 6/0/0 0.135
‡ 13/2/5 19/7/1 0.059
‡
Tumor size (cm)
* 3.5 (1.5-5.5) 3.5 (2.5-5.5) 0.699
† 3.75 (1.30-12.00) 4.00 (1.70-18.00) 0.627
†
Histologic grade, I/II/III/IV 0/2/1/3 0/1/2/3 0.717
‡ 4/8/6/2 3/7/13/4 0.481
‡
Portal vein invasion, no/yes 5/1 2/4 0.242
‡ 14/6 24/3 0.142
‡
HCC treatment, OP/LT 4/2 4/2 1.000
‡ 8/12 18/9 0.084
‡
Total bilirubin (mg/dL)
* 0.79 (0.59-1.01) 1.21 (0.80-8.40) 0.180
† 1.10 (0.48-32.15) 0.80 (0.39-16.69) 0.313
†
Albumin (g/dL)
* 3.85 (2.80-4.40) 3.25 (2.30-4.10) 0.310
† 3.45 (1.90-4.60) 3.70 (2.40-4.50) 0.804
†
Serum creatinine (mg/dL)
* 0.85 (0.75-8.45) 0.91 (0.60-2.17) 0.937
† 0.83 (0.70-1.58) 0.90 (0.51-10.54) 0.590
†
PT (INR)
* 1.06 (0.96-1.50) 1.17 (1.07-2.88) 0.180
† 1.23 (0.86-2.82) 1.12 (0.73-1.79) 0.621
†
AFP level (ng/mL)
* 362 (71.04-893.78) 324.26 (18.01-2475) 0.937
† 23.71 (1.26-1521.10) 238.79 (2.6-2907.02) 0.065
†
All data expressed as number of cases.
* Median (range), 
†Mann-Whitney test, 
‡Fisher’s exact test.
HBV, hepatitis B virus; HCV, hepatitis C virus; OP, operation; LT, liver transplantation; PT, prothrombin time; AFP, α-fetoprotein. 
The expression of Snail and E-cadherin and the 
postsurgical recurrence 
During the average 33 months of follow-up period (range, 
1-133 months) after operation, HCC recurred in 29 patients 
(49.1%) among the entire 59 patients. Among them, 16 cases 
(27.1%) was intrahepatic recurrence, 19 cases (32.2%) was 
extrahepatic metastasis, and intrahepatic recurrence and 
extrahepatic metastasis simultaneously occurred in 6 cases 
(10.1%).
HCC recurrence rate and survival rate after resection was 
not different according to the expression of Snail and 
E-cadherin. Nonetheless, in patients expressing Snail without 
the expression of E-cadherin, the recurrence rate of HCC 
after surgery was significantly higher than patients expressing 
both Snail and E-cadherin (P=0.013) (Fig. 2A). Meanwhile, 
in patients without Snail expression, HCC recurrence rate 
was not significantly different depending on the presence or 
absence of the expression of E-cadherin (P=0.251) (Fig. 2B). 
DISCUSSION
It has been shown that E-cadherin plays an important role 
in mediating cell to cell adhesion,
20 and the low expression 
of E-cadherin is closely associated with local invasion of 
tumor cells and distant metastasis.
20, 21 Several mechanisms 
controlling the expression of E-cadherin have been shown, 
and recently, Snail gene has been reported to be a mechanism 
suppressing E-cadherin. Snail is a gene discovered in 
Drosophila for the first time. It has been shown to play an 
essential role in the formation of the mesenchyme because 
Drosophila with the mutation in Snail could not form the 
mesenchyme and thus die in the embryonic period.
12,22 In 
addition, it has been reported that Snail suppress E-cadherin 
directly, accelerates the expression of matrix metalloproteinase, 
and thus involved in the transition of epithelial cells to 
mesenchymal cells as the important stage of metastasis.
13-15 
In recent studies, Snail has been reported to be overexpressed 
in 16-23% of HCC tissues, and expressed inversely to 
E-cadherin.
15,17,23 In our study, Snail was expressed in the HCC Hyun Young Woo, et al. Expression of Snail in hepatocellular carcinoma  17
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Figure 2. Cumulative recurrence-free survival rate of HCC according to immunohistochemical staining patterns of Snail and E-cadherin 
(Kaplan-Meier survival curve, P-value by log-rank test). (A) The cumulative recurrence-free survival rate of HCC is significantly 
higher in negative E-cadherin staining than in positive E-cadherin staining in the case of positive Snail staining. (B) The cumulative 
recurrence-free survival rate of HCC does not differ significantly according to the E-cadherin staining pattern in the case of negative 
Snail staining.
area of 20.3% of cases (12/59) and in the adjacent non-HCC 
area in 3.4% of cases (2/59). E-cadherin was expressed in 
44.1% of HCC area (26/59), however, the expression of 
E-cadherin in the non-HCC area was not examined addi-
tionally. However, according to studies reported previously, 
E-cadherin has been shown to be highly expressed in the 
non-HCC area in more than 90% of cases.
24 In addition, in 
our study, in all cases, the expression of E-cadherin was 
suppressed in the HCC area expressing Snail. Based on these 
results, in Korea where the major etiology is hepatitis B, 
Snail was overexpressed in HCC as comparable frequencies to 
other studies, and also, it was expressed inversely to E-cadherin.
It has been shown that Snail not only suppresses E-cadherin 
but also accelerates the infiltration of tumor cells in various 
malignant tumors.
25,26 The expression of Snail in HCC is 
associated with poorly differentiated histological grade, 
with capsular and vascular invasion, and related to post 
surgical intrahepatic recurrence.
15-17 In our study, in the 
association of the expression of Snail with clinicopathological 
characteristics, the histological grade of differentiation in 
HCC expressing Snail was poor with statistical significance. 
However, in regard to vascular invasion, although portal 
vein invasion was more frequent in HCC expressing Snail, it 
was not statistically significant. It has been shown that 
histological grade of differentiation and vascular invasion 
are closely related to the invasion and metastasis in HCC, 
and thus it could be predicted that the prognosis of HCC 
expressing Snail would be poorer than HCC without its 
expression. On the other hand, E-cadherin has been shown 
to be closely associated with the differentiation grade of 
HCC, and as the differentiation grade of primary HCC was 
poorer, the rate of the loss of the expression was high.
27 
However, in this study, E-cadherin did not show the 
significant association with any clinicopathological factors. 
Such results may be due to the insufficient number of included 
patients and the inhomogeneous subject patients in each study.
In our study, the expression of Snail or E-cadherin itself 
did not show the association with the recurrence rate of 
tumors after resection, although, in HCC expressing Snail 
without expressing E-cadherin, the recurrence rate after 
surgery was shown to be significantly higher than in HCC 
cases expressing both Snail and E-cadherin. Based on the 
results, it could be speculated that the expression of Snail 
was associated with the suppression of the expression of 
E-cadherin as well as the recurrence after surgical treatment. 
However, HCC expressing E-cadherin despite of the 
expression of Snail was present, and in such cases, poor 
prognosis as in the cases of HCC without expressing 
E-cadherin was not shown, and thus it is difficult to predict 
the effect on the postsurgical recurrence rate by the simple 
expression pattern of Snail and E-cadherin. In addition, the 
possibility that mechanisms other than Snail may be involved 
in the action mechanisms of E-cadherin could not be ruled 
out. In previous reports, it has been reported that in the 
mechanism of the regulation of E-cadherin, in addition to 
Snail, the hypermethylation of E-cadherin gene or the gene 
regulation area, or the loss of heterozygosity is involved in 
it.
28-30
In conclusion, Snail was expressed in approximately 20% 
of HCC cases. E-cadherin was also expressed in HCC, and 18  The Korean Journal of Hepatology Vol. 17. No. 1, March 2011
the expression was suppressed in the area expressing Snail. 
The expression of Snail was significantly increased in HCC 
with poor histological differentiation. Further studies on the 
association of the Snail expression with the recurrence of 
tumor after surgery would be needed.
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